These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 17064469

  • 1. [Changes of mast cells and protease activated receptor-2 in experimental rat liver fibrosis].
    Xu KS, Li Q, Zhou X.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):753-6. PubMed ID: 17064469
    [Abstract] [Full Text] [Related]

  • 2. [Expression of activins, follistatin mRNA in the development of hepatic fibrosis].
    Huang X, Li D, Lu H, Wang Z, Wei H, Wang Y, Zhang J, Xu Q.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):85-8. PubMed ID: 11983117
    [Abstract] [Full Text] [Related]

  • 3. [Relationship of protease-activated receptor-2 and mast cell in the rat model of small intestinal mucosal damage by short-term administration of non-steroidal anti-inflammatory drug].
    Chen MY, Lü B, Chen HQ, Zhang S.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 07; 91(21):1502-5. PubMed ID: 21914290
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
    Gong ZJ, Song SL, Huang YQ, Ruan P.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec 07; 12(12):737-40. PubMed ID: 15619341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC, Chung JJ.
    J Investig Med; 1994 Dec 07; 42(4):660-70. PubMed ID: 8521029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Dynamic evolution of MMP-13, TIMP-1, type I and III collagen and their interaction in experimental liver fibrosis].
    Zhu YK, Wang BE, Shen FJ, Wang AM, Jia JD, Ma H.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct 07; 12(10):612-5. PubMed ID: 15504294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
    Yang L, Chan CC, Kwon OS, Liu S, McGhee J, Stimpson SA, Chen LZ, Harrington WW, Symonds WT, Rockey DC.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov 07; 291(5):G902-11. PubMed ID: 16798724
    [Abstract] [Full Text] [Related]

  • 17. Kinetics of macrophages, myofibroblasts and mast cells in carbon tetrachloride-induced rat liver cirrhosis.
    Jeong WI, Lee CS, Park SJ, Chung JY, Jeong KS.
    Anticancer Res; 2002 Nov 07; 22(2A):869-77. PubMed ID: 12014664
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM, Atorrasagasti C, Maccio D, Prada F, Salvatierra E, Rizzo M, Alaniz L, Aquino JB, Podhajcer OL, Silva M, Mazzolini G.
    J Gene Med; 2008 Sep 07; 10(9):993-1004. PubMed ID: 18615449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis.
    Rioux KP, Sharkey KA, Wallace JL, Swain MG.
    Hepatology; 1996 Apr 07; 23(4):888-95. PubMed ID: 8666346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.